针对拓糖酶的药物的结构机制
Anthony C O'Donnell1, James M Berger1
1Department of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA;
Annual review of biochemistry
|March 24, 2025
概括
托波异相酶是管理DNA拓学的关键酶. 针对这些酶的现有和新型治疗药物为抗菌和抗瘤应用提供了显著的临床益处.
科学领域:
- 分子生物学分子生物学
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 拓相酶是解决DNA拓挑战的必需酶.
- 这些酶是抗菌和抗癌药物的验证标.
- 小分子抗剂可以抑制拓酶酶并诱导DNA损伤.
研究的目的:
- 审查当前拓酶抑制剂的分子机制.
- 讨论针对拓酶的新型治疗剂.
- 为了突出托皮索马酶向疗法的临床实用性.
主要方法:
- 拓酶功能的生物化学分析.
- 酶-抑制剂相互作用的结构生物学研究.
- 对治疗剂的临床前和临床数据的审查.
主要成果:
- 详细的分子洞察力如何现有的药物向真核生物和 prokaryotic topoisomerases.
- 确定具有潜在临床应用的有前途的新药物.
- 证明拓酶酶是药物开发的多功能标.
结论:
- 向拓酶仍然是开发抗菌和抗瘤疗法的高效策略.
- 了解分子相互作用是设计强效和选择性抑制剂的关键.
- 对新型药物的持续研究有望带来进一步的临床进展.
更多相关视频
10:12Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
2.6K
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
相关概念视频
DNA Topoisomerases
30.7K
Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
30.7K
Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
